Phillip Parente
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Cancer survivorship and care
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults
Papers in
-
- Prostate Cancer Treatment and Research 30
- Lung Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 3
- Oncology 26
- Cancer survivorship and care 8
- Cancer Immunotherapy and Biomarkers 6
- Cutaneous Melanoma Detection and Management 4
- Co-authors
- Ian D. Davis (15 shared papers)Jonathan Simon Cebon (7 shared papers)Michael Jefford (4 shared papers)Madeleine Trudy King (4 shared papers)Wee Kheng Soo (2 shared papers)Peteris J. Darzins (2 shared papers)Eugene Maraskovsky (5 shared papers)Heather M. Jackson (5 shared papers)
- Journals
- Annals of Oncology (9 papers)Supportive Care in Cancer (4 papers)Journal of Clinical Oncology (4 papers)The Lancet Oncology (3 papers)European Urology Focus (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Phillip Parente
82 papers receiving 2.9k citations
Phillip Parente's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 1.1k
- Geriatrics and Gerontology 143
- Immunology 641
- Pulmonary and Respiratory Medicine 650
- Cancer Research 65
Countries citing papers authored by Phillip Parente
This map shows the geographic impact of Phillip Parente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Parente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Parente more than expected).
Fields of papers citing papers by Phillip Parente
This network shows the impact of papers produced by Phillip Parente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Parente. The network helps show where Phillip Parente may publish in the future.
Co-authors
The 25 scholars most cited alongside Phillip Parente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 376 | |
| 2 | Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial Hit paper breakdown → | 2021 | 300 |
| 3 | 2017 | 210 | |
| 4 | 2018 | 180 | |
| 5 | Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial Hit paper breakdown → | 2022 | 148 |
| 6 | 2003 | 119 | |
| 7 | 2015 | 114 | |
| 8 | 2016 | 108 | |
| 9 | Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Hit paper breakdown → | 2024 | 108 |
| 10 | The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. | 2004 | 105 |
| 11 | 2020 | 97 | |
| 12 | 2004 | 79 | |
| 13 | 2006 | 62 | |
| 14 | 2014 | 61 | |
| 15 | 2021 | 60 | |
| 16 | 2021 | 59 | |
| 17 | 2015 | 56 | |
| 18 | 2016 | 47 | |
| 19 | 2019 | 47 | |
| 20 | 2021 | 42 |
About Phillip Parente
Phillip Parente is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Health Information Management and Geriatrics and Gerontology, having authored 84 papers that have together received 3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (30 papers), Cancer survivorship and care (8 papers), Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Cutaneous Melanoma Detection and Management (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Healthcare Quality and Management (3 papers). The work is most often cited by research in Oncology (1.1k citations), Geriatrics and Gerontology (143 citations), Immunology (641 citations), Pulmonary and Respiratory Medicine (650 citations) and Cancer Research (65 citations). Phillip Parente has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Ian D. Davis, Jonathan Simon Cebon, Michael Jefford, Madeleine Trudy King, Wee Kheng Soo, Peteris J. Darzins, Eugene Maraskovsky, Heather M. Jackson, Weisan Chen and Wendie Hopkins. Their work appears in journals such as Annals of Oncology, Supportive Care in Cancer, Journal of Clinical Oncology, The Lancet Oncology and European Urology Focus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.